According to Latest Research by Market IntelliX, the global market for Biomarker Analysis should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Biomarker Analysis market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Biomarker Analysis market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Diagnostic Biomarkers segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Diagnosis has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.
The global key manufacturers of Biomarker Analysis include Bio-Rad, Eurofins Scientific, Crown Bioscience, Meridian Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Roche Molecular Diagnostics, Abbott Laboratories and Agilent/Dako, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Biomarker analysis is the process of identifying and measuring biomarkers, which are biological molecules or characteristics that can serve as indicators of a particular disease, condition, or physiological state. Biomarkers can provide valuable information on disease diagnosis, prognosis, and treatment response, and can help tailor treatment options to individual patients.
This report aims to provide a comprehensive study of the global market for Biomarker Analysis. Report Highlights:
(1) Global Biomarker Analysis market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Biomarker Analysis market competitive situation, revenue and market share, from 2019 to 2024.
(3) China Biomarker Analysis market competitive situation, revenue and market share, from 2019 to 2024.
(4) Global Biomarker Analysis segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Biomarker Analysis segment by type and by application and regional segment by type and by application.
(6) Biomarker Analysis industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Diagnostic Biomarkers
Prognostic Biomarkers
Predictive Biomarkers
Safety Biomarkers
Surrogate Biomarkers
Market segment by application, can be divided into
Diagnosis
Prognosis
Treatment Selection
Monitoring
Clinical Trials
Market segment by players, this report covers
Bio-Rad
Eurofins Scientific
Crown Bioscience
Meridian Bioscience
Thermo Fisher Scientific Inc.
Siemens Healthineers
Roche Molecular Diagnostics
Abbott Laboratories
Agilent/Dako
Becton, Dickinson and Company
Eve Technologies
Fluidic Analytics
Hybrigenics Services
Luminex Corp
Qiagen
1 Market Overview
1.1 Product Overview and Scope of Biomarker Analysis
1.2 Global Biomarker Analysis Market Size and Forecast
1.3 China Biomarker Analysis Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Biomarker Analysis Share in Global Market, 2019-2030
1.4.2 Biomarker Analysis Market Size: China VS Global, 2019-2030
1.5 Biomarker Analysis Market Dynamics
1.5.1 Biomarker Analysis Market Drivers
1.5.2 Biomarker Analysis Market Restraints
1.5.3 Biomarker Analysis Industry Trends
1.5.4 Biomarker Analysis Industry Policy
2 Global Competitive Situation by Company
2.1 Global Biomarker Analysis Revenue by Company (2019-2024)
2.2 Global Biomarker Analysis Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Biomarker Analysis Concentration Ratio
2.4 Global Biomarker Analysis Mergers & Acquisitions, Expansion Plans
2.5 Global Biomarker Analysis Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Biomarker Analysis Revenue by Company (2019-2024)
3.2 China Biomarker Analysis Biomarker Analysis Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Biomarker Analysis, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)
4 Industry Chain Analysis
4.1 Biomarker Analysis Industry Chain
4.2 Biomarker Analysis Upstream Analysis
4.3 Biomarker Analysis Midstream Analysis
4.4 Biomarker Analysis Downstream Analysis
5 Sights by Type
5.1 Biomarker Analysis Classification
5.1.1 Diagnostic Biomarkers
5.1.2 Prognostic Biomarkers
5.1.3 Predictive Biomarkers
5.1.4 Safety Biomarkers
5.1.5 Surrogate Biomarkers
5.2 By Type, Global Biomarker Analysis Market Size & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Biomarker Analysis Revenue, 2019-2030
6 Sights by Application
6.1 Biomarker Analysis Segment by Application
6.1.1 Diagnosis
6.1.2 Prognosis
6.1.3 Treatment Selection
6.1.4 Monitoring
6.1.5 Clinical Trials
6.2 By Application, Global Biomarker Analysis Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Biomarker Analysis Revenue, 2019-2030
7 Sales Sights by Region
7.1 By Region, Global Biomarker Analysis Market Size, 2019 VS 2024 VS 2030
7.2 By Region, Global Biomarker Analysis Market Size, 2019-2030
7.3 North America
7.3.1 North America Biomarker Analysis Market Size & Forecasts, 2019-2030
7.3.2 By Country, North America Biomarker Analysis Market Size Market Share
7.4 Europe
7.4.1 Europe Biomarker Analysis Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Biomarker Analysis Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biomarker Analysis Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Biomarker Analysis Market Size Market Share
7.6 South America
7.6.1 South America Biomarker Analysis Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Biomarker Analysis Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Biomarker Analysis Market Size & CAGR,2019 VS 2024 VS 2030
8.2 By Country, Global Biomarker Analysis Market Size, 2019-2030
8.3 U.S.
8.3.1 U.S. Biomarker Analysis Market Size, 2019-2030
8.3.2 By Company, U.S. Biomarker Analysis Revenue Market Share, 2019-2024
8.3.3 By Type, U.S. Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.3.4 By Application, U.S. Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.4 Europe
8.4.1 Europe Biomarker Analysis Market Size, 2019-2030
8.4.2 By Company, Europe Biomarker Analysis Revenue Market Share, 2019-2024
8.4.3 By Type, Europe Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.4.4 By Application, Europe Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.5 China
8.5.1 China Biomarker Analysis Market Size, 2019-2030
8.5.2 By Company, China Biomarker Analysis Revenue Market Share, 2019-2024
8.5.3 By Type, China Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.5.4 By Application, China Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.6 Japan
8.6.1 Japan Biomarker Analysis Market Size, 2019-2030
8.6.2 By Company, Japan Biomarker Analysis Revenue Market Share, 2019-2024
8.6.3 By Type, Japan Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.6.4 By Application, Japan Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Biomarker Analysis Market Size, 2019-2030
8.7.2 By Company, South Korea Biomarker Analysis Revenue Market Share, 2019-2024
8.7.3 By Type, South Korea Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.7.4 By Application, South Korea Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Biomarker Analysis Market Size, 2019-2030
8.8.2 By Company, Southeast Asia Biomarker Analysis Revenue Market Share, 2019-2024
8.8.3 By Type, Southeast Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.8.4 By Application, Southeast Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.9 India
8.9.1 India Biomarker Analysis Market Size, 2019-2030
8.9.2 By Company, India Biomarker Analysis Revenue Market Share, 2019-2024
8.9.3 By Type, India Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.9.4 By Application, India Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.10 Middle East & Asia
8.10.1 Middle East & Asia Biomarker Analysis Market Size, 2019-2030
8.10.2 By Company, Middle East & Asia Biomarker Analysis Revenue Market Share, 2019-2024
8.10.3 By Type, Middle East & Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
8.10.4 By Application, Middle East & Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
9 Global Manufacturers Profile
9.1 Bio-Rad
9.1.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
9.1.2 Bio-Rad Company Profile and Main Business
9.1.3 Bio-Rad Biomarker Analysis Models, Specifications and Application
9.1.4 Bio-Rad Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.1.5 Bio-Rad Recent Developments
9.2 Eurofins Scientific
9.2.1 Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
9.2.2 Eurofins Scientific Company Profile and Main Business
9.2.3 Eurofins Scientific Biomarker Analysis Models, Specifications and Application
9.2.4 Eurofins Scientific Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.2.5 Eurofins Scientific Recent Developments
9.3 Crown Bioscience
9.3.1 Crown Bioscience Company Information, Head Office, Market Area and Industry Position
9.3.2 Crown Bioscience Company Profile and Main Business
9.3.3 Crown Bioscience Biomarker Analysis Models, Specifications and Application
9.3.4 Crown Bioscience Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.3.5 Crown Bioscience Recent Developments
9.4 Meridian Bioscience
9.4.1 Meridian Bioscience Company Information, Head Office, Market Area and Industry Position
9.4.2 Meridian Bioscience Company Profile and Main Business
9.4.3 Meridian Bioscience Biomarker Analysis Models, Specifications and Application
9.4.4 Meridian Bioscience Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.4.5 Meridian Bioscience Recent Developments
9.5 Thermo Fisher Scientific Inc.
9.5.1 Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area and Industry Position
9.5.2 Thermo Fisher Scientific Inc. Company Profile and Main Business
9.5.3 Thermo Fisher Scientific Inc. Biomarker Analysis Models, Specifications and Application
9.5.4 Thermo Fisher Scientific Inc. Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.5.5 Thermo Fisher Scientific Inc. Recent Developments
9.6 Siemens Healthineers
9.6.1 Siemens Healthineers Company Information, Head Office, Market Area and Industry Position
9.6.2 Siemens Healthineers Company Profile and Main Business
9.6.3 Siemens Healthineers Biomarker Analysis Models, Specifications and Application
9.6.4 Siemens Healthineers Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.6.5 Siemens Healthineers Recent Developments
9.7 Roche Molecular Diagnostics
9.7.1 Roche Molecular Diagnostics Company Information, Head Office, Market Area and Industry Position
9.7.2 Roche Molecular Diagnostics Company Profile and Main Business
9.7.3 Roche Molecular Diagnostics Biomarker Analysis Models, Specifications and Application
9.7.4 Roche Molecular Diagnostics Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.7.5 Roche Molecular Diagnostics Recent Developments
9.8 Abbott Laboratories
9.8.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
9.8.2 Abbott Laboratories Company Profile and Main Business
9.8.3 Abbott Laboratories Biomarker Analysis Models, Specifications and Application
9.8.4 Abbott Laboratories Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.8.5 Abbott Laboratories Recent Developments
9.9 Agilent/Dako
9.9.1 Agilent/Dako Company Information, Head Office, Market Area and Industry Position
9.9.2 Agilent/Dako Company Profile and Main Business
9.9.3 Agilent/Dako Biomarker Analysis Models, Specifications and Application
9.9.4 Agilent/Dako Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.9.5 Agilent/Dako Recent Developments
9.10 Becton, Dickinson and Company
9.10.1 Becton, Dickinson and Company Company Information, Head Office, Market Area and Industry Position
9.10.2 Becton, Dickinson and Company Company Profile and Main Business
9.10.3 Becton, Dickinson and Company Biomarker Analysis Models, Specifications and Application
9.10.4 Becton, Dickinson and Company Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.10.5 Becton, Dickinson and Company Recent Developments
9.11 Eve Technologies
9.11.1 Eve Technologies Company Information, Head Office, Market Area and Industry Position
9.11.2 Eve Technologies Company Profile and Main Business
9.11.3 Eve Technologies Biomarker Analysis Models, Specifications and Application
9.11.4 Eve Technologies Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.11.5 Eve Technologies Recent Developments
9.12 Fluidic Analytics
9.12.1 Fluidic Analytics Company Information, Head Office, Market Area and Industry Position
9.12.2 Fluidic Analytics Company Profile and Main Business
9.12.3 Fluidic Analytics Biomarker Analysis Models, Specifications and Application
9.12.4 Fluidic Analytics Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.12.5 Fluidic Analytics Recent Developments
9.13 Hybrigenics Services
9.13.1 Hybrigenics Services Company Information, Head Office, Market Area and Industry Position
9.13.2 Hybrigenics Services Company Profile and Main Business
9.13.3 Hybrigenics Services Biomarker Analysis Models, Specifications and Application
9.13.4 Hybrigenics Services Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.13.5 Hybrigenics Services Recent Developments
9.14 Luminex Corp
9.14.1 Luminex Corp Company Information, Head Office, Market Area and Industry Position
9.14.2 Luminex Corp Company Profile and Main Business
9.14.3 Luminex Corp Biomarker Analysis Models, Specifications and Application
9.14.4 Luminex Corp Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.14.5 Luminex Corp Recent Developments
9.15 Qiagen
9.15.1 Qiagen Company Information, Head Office, Market Area and Industry Position
9.15.2 Qiagen Company Profile and Main Business
9.15.3 Qiagen Biomarker Analysis Models, Specifications and Application
9.15.4 Qiagen Biomarker Analysis Revenue and Gross Margin, 2019-2024
9.15.5 Qiagen Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Biomarker Analysis Market Size & CAGR: China VS Global, (US$ Million), 2019-2030
Table 2. Biomarker Analysis Market Restraints
Table 3. Biomarker Analysis Market Trends
Table 4. Biomarker Analysis Industry Policy
Table 5. Global Biomarker Analysis Revenue by Company (2019-2024) & (US$ million)
Table 6. Global Biomarker Analysis Revenue Market Share by Company (2019-2024)
Table 7. Global Biomarker Analysis Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Biomarker Analysis Mergers & Acquisitions, Expansion Plans
Table 9. Global Biomarker Analysis Manufacturers Product Type
Table 10. China Biomarker Analysis Revenue by Company (2019-2024) & (US$ million)
Table 11. China Biomarker Analysis Revenue Market Share by Company (2019-2024)
Table 12. Global Key Players of Biomarker Analysis Upstream (Raw Materials)
Table 13. Global Biomarker Analysis Typical Customers
Table 14. Biomarker Analysis Typical Distributors
Table 15. By Type, Global Biomarker Analysis Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 16. By Application, Global Biomarker Analysis Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 17. By Region, Global Biomarker Analysis Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 18. By Region, Global Biomarker Analysis Revenue, 2019-2030, US$ Million
Table 19. By Country, Global Biomarker Analysis Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 20. By Country, Global Biomarker Analysis Revenue, 2019-2030, US$ Million
Table 21. By Country, Global Biomarker Analysis Revenue Market Share, 2019-2030
Table 22. Bio-Rad Company Information, Head Office, Market Area and Industry Position
Table 23. Bio-Rad Company Profile and Main Business
Table 24. Bio-Rad Biomarker Analysis Models, Specifications and Application
Table 25. Bio-Rad Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 26. Bio-Rad Recent Developments
Table 27. Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
Table 28. Eurofins Scientific Company Profile and Main Business
Table 29. Eurofins Scientific Biomarker Analysis Models, Specifications and Application
Table 30. Eurofins Scientific Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 31. Eurofins Scientific Recent Developments
Table 32. Crown Bioscience Company Information, Head Office, Market Area and Industry Position
Table 33. Crown Bioscience Company Profile and Main Business
Table 34. Crown Bioscience Biomarker Analysis Models, Specifications and Application
Table 35. Crown Bioscience Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 36. Crown Bioscience Recent Developments
Table 37. Meridian Bioscience Company Information, Head Office, Market Area and Industry Position
Table 38. Meridian Bioscience Company Profile and Main Business
Table 39. Meridian Bioscience Biomarker Analysis Models, Specifications and Application
Table 40. Meridian Bioscience Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 41. Meridian Bioscience Recent Developments
Table 42. Thermo Fisher Scientific Inc. Company Information, Head Office, Market Area and Industry Position
Table 43. Thermo Fisher Scientific Inc. Company Profile and Main Business
Table 44. Thermo Fisher Scientific Inc. Biomarker Analysis Models, Specifications and Application
Table 45. Thermo Fisher Scientific Inc. Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 46. Thermo Fisher Scientific Inc. Recent Developments
Table 47. Siemens Healthineers Company Information, Head Office, Market Area and Industry Position
Table 48. Siemens Healthineers Company Profile and Main Business
Table 49. Siemens Healthineers Biomarker Analysis Models, Specifications and Application
Table 50. Siemens Healthineers Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 51. Siemens Healthineers Recent Developments
Table 52. Roche Molecular Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 53. Roche Molecular Diagnostics Company Profile and Main Business
Table 54. Roche Molecular Diagnostics Biomarker Analysis Models, Specifications and Application
Table 55. Roche Molecular Diagnostics Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 56. Roche Molecular Diagnostics Recent Developments
Table 57. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
Table 58. Abbott Laboratories Company Profile and Main Business
Table 59. Abbott Laboratories Biomarker Analysis Models, Specifications and Application
Table 60. Abbott Laboratories Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 61. Abbott Laboratories Recent Developments
Table 62. Agilent/Dako Company Information, Head Office, Market Area and Industry Position
Table 63. Agilent/Dako Company Profile and Main Business
Table 64. Agilent/Dako Biomarker Analysis Models, Specifications and Application
Table 65. Agilent/Dako Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 66. Agilent/Dako Recent Developments
Table 67. Becton, Dickinson and Company Company Information, Head Office, Market Area and Industry Position
Table 68. Becton, Dickinson and Company Company Profile and Main Business
Table 69. Becton, Dickinson and Company Biomarker Analysis Models, Specifications and Application
Table 70. Becton, Dickinson and Company Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 71. Becton, Dickinson and Company Recent Developments
Table 72. Eve Technologies Company Information, Head Office, Market Area and Industry Position
Table 73. Eve Technologies Company Profile and Main Business
Table 74. Eve Technologies Biomarker Analysis Models, Specifications and Application
Table 75. Eve Technologies Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 76. Eve Technologies Recent Developments
Table 77. Fluidic Analytics Company Information, Head Office, Market Area and Industry Position
Table 78. Fluidic Analytics Company Profile and Main Business
Table 79. Fluidic Analytics Biomarker Analysis Models, Specifications and Application
Table 80. Fluidic Analytics Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 81. Fluidic Analytics Recent Developments
Table 82. Hybrigenics Services Company Information, Head Office, Market Area and Industry Position
Table 83. Hybrigenics Services Company Profile and Main Business
Table 84. Hybrigenics Services Biomarker Analysis Models, Specifications and Application
Table 85. Hybrigenics Services Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 86. Hybrigenics Services Recent Developments
Table 87. Luminex Corp Company Information, Head Office, Market Area and Industry Position
Table 88. Luminex Corp Company Profile and Main Business
Table 89. Luminex Corp Biomarker Analysis Models, Specifications and Application
Table 90. Luminex Corp Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 91. Luminex Corp Recent Developments
Table 92. Qiagen Company Information, Head Office, Market Area and Industry Position
Table 93. Qiagen Company Profile and Main Business
Table 94. Qiagen Biomarker Analysis Models, Specifications and Application
Table 95. Qiagen Biomarker Analysis Revenue and Gross Margin, 2019-2024
Table 96. Qiagen Recent Developments
List of Figure
Figure 1. Biomarker Analysis Picture
Figure 2. Global Biomarker Analysis Industry Market Size and Forecast (US$ million) & (2019-2030)
Figure 3. China Biomarker Analysis Revenue and Forecast (US$ million) & (2019-2030)
Figure 4. 2019-2030 China Biomarker Analysis Market Share of Global
Figure 5. Global Biomarker Analysis Key Participants, Market Share, 2021 VS 2024 VS 2024
Figure 6. Global Biomarker Analysis Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024
Figure 7. China Biomarker Analysis Key Participants, Market Share, 2021 VS 2024 VS 2024
Figure 8. China Biomarker Analysis Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 9. Biomarker Analysis Industry Chain
Figure 10. Diagnostic Biomarkers
Figure 11. Prognostic Biomarkers
Figure 12. Predictive Biomarkers
Figure 13. Safety Biomarkers
Figure 14. Surrogate Biomarkers
Figure 15. By Type, Global Biomarker Analysis Revenue, 2019-2030, US$ Million
Figure 16. By Type, Global Biomarker Analysis Revenue Market Share, 2019-2030
Figure 17. Diagnosis
Figure 18. Prognosis
Figure 19. Treatment Selection
Figure 20. Monitoring
Figure 21. Clinical Trials
Figure 22. By Application, Global Biomarker Analysis Revenue, 2019-2030, US$ Million
Figure 23. By Application, Global Biomarker Analysis Revenue Market Share, 2019-2030
Figure 24. By Region, Global Biomarker Analysis Revenue Market Share, 2019-2030
Figure 25. North America Biomarker Analysis Revenue & Forecasts, 2019-2030, US$ Million
Figure 26. By Country, North America Biomarker Analysis Revenue Market Share, 2019-2024
Figure 27. Europe Biomarker Analysis Revenue & Forecasts, 2019-2030, US$ Million
Figure 28. By Country, Europe Biomarker Analysis Revenue Market Share, 2019-2024
Figure 29. Asia Pacific Biomarker Analysis Revenue & Forecasts, 2019-2030, US$ Million
Figure 30. By Country/Region, Asia Pacific Biomarker Analysis Revenue Market Share, 2019-2024
Figure 31. South America Biomarker Analysis Revenue & Forecasts, 2019-2030, US$ Million
Figure 32. By Country, South America Biomarker Analysis Revenue Market Share, 2019-2024
Figure 33. Middle East & Africa Biomarker Analysis Revenue & Forecasts, 2019-2030, US$ Million
Figure 34. U.S. Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 35. By Company, U.S. Biomarker Analysis Market Share, 2019-2024
Figure 36. By Type, U.S. Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 37. By Application, U.S. Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 38. Europe Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 39. By Company, Europe Biomarker Analysis Market Share, 2019-2024
Figure 40. By Type, Europe Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 41. By Application, Europe Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 42. China Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 43. By Company, China Biomarker Analysis Market Share, 2019-2024
Figure 44. By Type, China Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 45. By Application, China Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 46. Japan Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 47. By Company, Japan Biomarker Analysis Market Share, 2019-2024
Figure 48. By Type, Japan Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 49. By Application, Japan Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 50. South Korea Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 51. By Company, South Korea Biomarker Analysis Market Share, 2019-2024
Figure 52. By Type, South Korea Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 53. By Application, South Korea Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 54. Southeast Asia Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 55. By Company, Southeast Asia Biomarker Analysis Market Share, 2019-2024
Figure 56. By Type, Southeast Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 57. By Application, Southeast Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 58. India Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 59. By Company, India Biomarker Analysis Market Share, 2019-2024
Figure 60. By Type, India Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 61. By Application, India Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 62. Middle East & Asia Biomarker Analysis Revenue, 2019-2030, (US$ Million)
Figure 63. By Company, Middle East & Asia Biomarker Analysis Market Share, 2019-2024
Figure 64. By Type, Middle East & Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 65. By Application, Middle East & Asia Biomarker Analysis Revenue Market Share, 2024 VS 2030
Figure 66. Research Methodology
Figure 67. Breakdown of Primary Interviews
Figure 68. Bottom-up Approaches
Figure 69. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|